Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Aviva plc    AV.   GB0002162385

AVIVA PLC

(AV.)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Aviva: Recommended all-share acquisition of Friends Life Group Limited by Aviva plc

09/29/2020 | 09:45am EST

Aviva plc and Friends Life Group Limited are pleased to announce that they have reached agreement on the terms of a recommended all share acquisition of Friends Life Group Limited by Aviva plc.

Shareholders will have an opportunity to vote on the proposed acquisition at a general meeting. We will write to shareholders with details of the general meeting and how to vote in due course.

All documentation relating to this will be published on this website.

Offer announcement

Recommended All-Share Acquisition of Friends Life Group Ltd by Aviva plc PDF (0.7MB)

SEC filing - Recommended All-Share Acquisition of Friends Life Group Ltd by Aviva plc

Friends Life Acquisition Analyst Presentation PDF (0.7MB)

FAQ for Aviva shareholders

What is an all share offer?

  • In an all-share offer, Aviva plc would issue Aviva plc ordinary 25p shares to Friends Life Group Limited shareholders (typically at a set ratio including a premium) rather than paying cash to Friends Life Group Limited shareholders.
  • As a result, both Aviva plc and Friends Life Group Limited shareholders would have a position in the enlarged group.
  • There would be no debt raise required to finance the transaction

What does this mean for my shareholding in Aviva plc?

  • If the proposed combination were to proceed, we would currently expect:
  • that the combined group would have higher cash flows enhanced by substantial synergies, principally through operating efficiencies in the combined back books and the removal of overlapping overheads
  • accelerated transformation of Aviva's balance sheet, including reducing leverage and strengthening capital and liquidity. This is expected to increase the enlarged group's financial and strategic flexibility and support further growth of Aviva's dividends.

Will my shareholding in Aviva plc be diluted?

  • Yes. If the proposed combination were to proceed, Aviva plc shareholders will own approximately 74% of the enlarged company, Friends Life Group Limited shareholders will own approximately 26% of the enlarged company.

Will I get the chance to vote on this deal?

  • Yes, the combination constitutes a Class 1 transaction for Aviva plc.
  • Aviva plc therefore requires approval from its shareholders at a general meeting which will be scheduled in due course (probably in March 2015). It is intended that the Scheme document, prospectus and circular (including notice of the general meeting) will be published in the second half of January 2015.
  • If the proposed acquisition is successful then the transaction is expected to complete during the second quarter of 2015.

When will the general meeting to approve the transaction be?

  • We will contact you in due course but a general meeting is likely to be scheduled for March 2015.

Offer related documents

Opening Position Disclosure - Offer in Aviva plc PDF (0.2MB)

Opening Position Disclosure - Offer in Friends Life Group Limited PDF (0.2 MB)

Aviva/Friends Life Co-operation Agreement PDF (1.0MB)

Aviva/Friends Life Non-Disclosure Agreement PDF (4.5MB)

Deloitte Rule 23.3 Consent Letter PDF (0.02MB)

JPMorgan Cazenove Rule 23.3 Consent Letter PDF (0.02MB)

Morgan Stanley Rule 23.3 Consent Letter PDF (0.03MB)

Robey Warshaw Rule 23.3 Consent Letter PDF (0.2MB)

Deloitte QFBS Public Opinion PDF (0.03MB)

Financial Advisor's QFBS Public Opinion PDF (0.03MB)

Deeds of Irrevocable Undertaking from Aviva plc directors

John McFarlane PDF (1.2MB)

Mark Wilson PDF (1.4MB)

Sir Adrian Montague PDF (1.3MB)

Glyn Barker PDF (1.2MB)

Patricia Cross PDF (1.3MB)

Michael Hawker PDF (1.2MB)

Gay Huey Evans PDF (1.5 MB)

Michael Mire PDF (1.2MB)

Bob Stein PDF (1.3MB)

Scott Wheway PDF (1.3MB)

Deeds of Irrevocable Undertaking from Friends Life Group Limited directors

Sir Malcolm Williamson PDF (0.6MB)

Andy Briggs PDF (0.7MB)

Tim Tookey PDF (0.6MB)

Mel Carvill PDF (0.2MB)

Nicholas Lyons PDF (0.2MB)

Robin Phipps PDF (0.2MB)

Tim Wade PDF (0.6MB)

Disclaimer

Aviva plc published this content on 04 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 September 2020 13:44:07 UTC


© Publicnow 2020
All news about AVIVA PLC
05:15pLondon stocks end at multi-month highs on vaccine optimism, commodity gains
RE
07:41aGold mining emissions draw scrutiny after price surge
RE
11/23NEWS HIGHLIGHTS : Top Financial Services News of the Day
DJ
11/23Gold mining emissions draw scrutiny after price surge
RE
11/23NEWS HIGHLIGHTS : Top Financial Services News of the Day
DJ
11/23NEWS HIGHLIGHTS : Top Financial Services News of the Day
DJ
11/23European Insurers Gear Up to Do Deals
DJ
11/23AVIVA : to sell its entire shareholding in Aviva Vita
PU
11/23AVIVA : sells Vita stake to UBI Banca as part of group overhaul
RE
11/23AVIVA : Sells Italian Subsidiary for EUR400 Million
DJ
More news
Financials
Sales 2020 46 319 M 61 891 M 61 891 M
Net income 2020 1 574 M 2 104 M 2 104 M
Net Debt 2020 5 016 M 6 702 M 6 702 M
P/E ratio 2020 8,32x
Yield 2020 7,31%
Capitalization 13 262 M 17 709 M 17 721 M
EV / Sales 2020 0,39x
EV / Sales 2021 0,40x
Nbr of Employees 31 181
Free-Float 97,1%
Chart AVIVA PLC
Duration : Period :
Aviva plc Technical Analysis Chart | AV. | GB0002162385 | MarketScreener
Technical analysis trends AVIVA PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 368,71 GBX
Last Close Price 3,38 GBX
Spread / Highest target 16 922%
Spread / Average Target 10 815%
Spread / Lowest Target 6 307%
EPS Revisions
Managers
NameTitle
Amanda Blanc Chief Executive Officer & Director
Mark George Culmer Non-Executive Chairman
Nitinbhai Babubhai Maganbhai Amin Chief Operating Officer
Jason Michael Windsor CFO, Executive Director & Chief Investment Officer
Michael Mire Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
AVIVA PLC-22.47%16 936
AXA-24.47%53 404
PRUDENTIAL PLC-12.70%43 684
METLIFE, INC.-7.46%42 451
MANULIFE FINANCIAL CORPORATION-18.44%32 167
AFLAC INCORPORATED-15.97%31 224